Clementine A Lemaire
Overview
Explore the profile of Clementine A Lemaire including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
92
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Razmara A, Sollier E, Kisirkoi G, Baker S, Bellon M, McMillan A, et al.
Clin Exp Metastasis
. 2020 Apr;
37(3):413-424.
PMID: 32335861
Patient-derived orthotopic xenograft (PDOX) models have been verified as a useful method for studying human cancers in mice. Previous studies on the extent of metastases in these models have been...
2.
Ramani V, Lemaire C, Triboulet M, Casey K, Heirich K, Renier C, et al.
Breast Cancer Res
. 2019 Aug;
21(1):98.
PMID: 31462307
Background: Circulating tumor cells (CTCs) represent a temporal "snapshot" of a patient's cancer and changes that occur during disease evolution. There is an extensive literature studying CTCs in breast cancer...
3.
Renier C, Pao E, Che J, Liu H, Lemaire C, Matsumoto M, et al.
NPJ Precis Oncol
. 2018 Jun;
1(1):15.
PMID: 29872702
There has been increased interest in utilizing non-invasive "liquid biopsies" to identify biomarkers for cancer prognosis and monitoring, and to isolate genetic material that can predict response to targeted therapies....
4.
Lemaire C, Liu S, Wilkerson C, Ramani V, Barzanian N, Huang K, et al.
SLAS Technol
. 2018 Jan;
23(1):16-29.
PMID: 29355087
Tumor tissue biopsies are invasive, costly, and collect a limited cell population not completely reflective of patient cancer cell diversity. Circulating tumor cells (CTCs) can be isolated from a simple...